What smart money is saying about Elevance Health, Inc.
5 funds in our archive have pitched Elevance Health, Inc. — most recently Hotchkis & Wiley Large Cap Fundamental Value in March 2026.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Fund coverage · 5 theses
- Hotchkis & Wiley Large Cap Fundamental ValueMarch 2026
Elevance Health, Inc. is a large, high-quality insurer trading at a discount with long-term growth and margin improvement potential despite near-term policy headwinds.
Read the full thesis - Meditation CapitalDecember 2025
Elevance Health is a diversified insurer with a strong Anthem Blue Cross Blue Shield brand, attractive valuation and margin normalization potential, and possible AI-driven efficiencies supporting a ~25% 4-year IRR.
Read the full thesis - Sequoia FundDecember 2025
Elevance Health is a deeply entrenched insurer with cyclical margin headwinds in government lines that should normalize, trading at a single-digit multiple of normalized earnings.
Read the full thesis - BA Beutel Goodman US Value FundJune 2025
Elevance Health Inc. is a major managed care organization poised for growth due to favorable trends in government outsourcing and value-based care, despite current margin pressures.
Read the full thesis - Harris Global Concentrated StrategyDecember 2024
Elevance Health is poised for recovery as its stock, currently undervalued due to temporary industry challenges, is expected to bounce back, reflecting its quality and growth potential.
Read the full thesis
Read every full thesis on Elevance Health, Inc.
Unlock all 5 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→